Lindbrook Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Lindbrook Capital’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12	Closed	-$461	–	2865
2023 Q2	$461	Buy	+12	New	+$308	﹤0.01%	2530

Lindbrook Capital's KDNY Position: Q3 2023 in Review

Lindbrook Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 12 shares — an estimated $461 sold.

Lindbrook Capital first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $461 in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Lindbrook Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Lindbrook Capital sold 12 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $461.
Lindbrook Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Lindbrook Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $461 in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.